• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve.载脂蛋白 B 与非高密度脂蛋白胆固醇在动脉粥样硬化性心血管疾病风险评估中的应用:探索与解释“U”型曲线。
Curr Cardiol Rep. 2023 Dec;25(12):1725-1733. doi: 10.1007/s11886-023-01987-3. Epub 2023 Nov 16.
2
Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?高密度脂蛋白胆固醇升高能预防心血管疾病吗?
J Clin Endocrinol Metab. 2024 Jan 18;109(2):321-332. doi: 10.1210/clinem/dgad406.
3
The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis.高密度脂蛋白与动脉粥样硬化性心血管疾病的阴阳两面:聚焦功能与胆固醇外排以重新构建高密度脂蛋白假说。
Curr Med Chem. 2021;28(29):6066-6081. doi: 10.2174/0929867328666210208182326.
4
Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.成人生命历程中血脂浓度的变化轨迹与心血管疾病和全因死亡率的风险:弗雷明汉研究 35 年来的观察结果。
J Am Heart Assoc. 2019 Jun 4;8(11):e011433. doi: 10.1161/JAHA.118.011433. Epub 2019 May 29.
5
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.降低“极高”ASCVD 风险患者的靶向致动脉粥样硬化脂蛋白胆固醇目标。
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.
6
Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study.研究低密度脂蛋白胆固醇与新发慢性肾脏病、动脉粥样硬化性心血管疾病及全因死亡率之间的线性和非线性关联:一项前瞻性和孟德尔随机化研究。
Atherosclerosis. 2023 Dec;387:117394. doi: 10.1016/j.atherosclerosis.2023.117394. Epub 2023 Nov 19.
7
High-Density Lipoprotein Subfractions Remodeling: A Critical Process for the Treatment of Atherosclerotic Cardiovascular Diseases.高密度脂蛋白亚组份重塑:动脉粥样硬化性心血管疾病治疗的关键过程。
Angiology. 2024 May;75(5):441-453. doi: 10.1177/00033197231157473. Epub 2023 Feb 14.
8
Sex-Specific U-Shaped Relationships Between High-Density Lipoprotein Cholesterol Levels and 10-year Major Adverse Cardiovascular Events: A Nationwide Cohort Study of 5.7 Million South Koreans.高密度脂蛋白胆固醇水平与 10 年主要不良心血管事件之间的性别特异性 U 型关系:一项涉及 570 万韩国人的全国队列研究。
Ann Lab Med. 2022 Jul 1;42(4):415-427. doi: 10.3343/alm.2022.42.4.415.
9
Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.非高密度脂蛋白胆固醇和载脂蛋白 B 与 LDL 胆固醇在动脉粥样硬化性心血管疾病风险评估中的比较。
Pathology. 2019 Feb;51(2):148-154. doi: 10.1016/j.pathol.2018.11.006. Epub 2018 Dec 27.
10
Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.载脂蛋白 B、非高密度脂蛋白胆固醇和三酰甘油不匹配:对心血管预防的影响。
Eur Heart J. 2024 Jul 12;45(27):2410-2418. doi: 10.1093/eurheartj/ehae258.

引用本文的文献

1
Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights.载脂蛋白A(ApoA)在神经系统疾病中的关联与见解
Int J Mol Sci. 2025 Aug 16;26(16):7908. doi: 10.3390/ijms26167908.
2
The prevalence and clinical correlates of severe anxiety symptoms in first-episode drug-naïve schizophrenia: a Chinese population study.首发未用药精神分裂症患者中严重焦虑症状的患病率及其临床相关性:一项中国人群研究。
BMC Psychiatry. 2025 Jul 30;25(1):743. doi: 10.1186/s12888-025-07197-1.
3
Extremely high HDL cholesterol paradoxically increases the risk of all-cause mortality in non-diabetic males from the Korean population: Korean genome and epidemiology study-health examinees (KoGES-HEXA) cohorts.极高的高密度脂蛋白胆固醇反而会增加韩国非糖尿病男性全因死亡风险:韩国基因组与流行病学研究——健康体检者(KoGES-HEXA)队列研究。
Front Med (Lausanne). 2025 May 15;12:1534524. doi: 10.3389/fmed.2025.1534524. eCollection 2025.
4
Atherogenic lipid parameters in people with normal glucose tolerance: implications from elevated 1-hour post-load plasma glucose.糖耐量正常人群的致动脉粥样硬化脂质参数:负荷后1小时血浆葡萄糖升高的影响
Cardiovasc Diabetol. 2025 May 14;24(1):207. doi: 10.1186/s12933-025-02722-8.
5
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease.血脂异常遗传学与动脉粥样硬化性心血管疾病风险的综合综述
Nutrients. 2025 Feb 12;17(4):659. doi: 10.3390/nu17040659.
6
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES.基于美国国家健康与营养检查调查(NHANES)的美国成年人中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与肝脂肪变性和肝纤维化之间的关联。
Sci Rep. 2025 Feb 23;15(1):6527. doi: 10.1038/s41598-025-90773-y.
7
Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program.心肌梗死后心脏康复计划后高密度脂蛋白胆固醇的动态变化
Rev Cardiovasc Med. 2025 Jan 13;26(1):25399. doi: 10.31083/RCM25399. eCollection 2025 Jan.
8
Association Between High-Density Lipoprotein Cholesterol and Length of Hospital Stay in Acute Pancreatitis: A Retrospective Cohort Study.高密度脂蛋白胆固醇与急性胰腺炎住院时间的关联:一项回顾性队列研究。
Int J Gen Med. 2024 Dec 30;17:6545-6556. doi: 10.2147/IJGM.S487993. eCollection 2024.
9
The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2.基于社区的 2 型糖尿病患者的血清高密度脂蛋白胆固醇、心血管疾病与死亡率之间的关系:弗里曼特尔糖尿病研究第二阶段。
Cardiovasc Diabetol. 2024 Oct 14;23(1):362. doi: 10.1186/s12933-024-02447-0.
10
Coronary Artery Calcium for Risk Stratification Among Persons With Very High HDL Cholesterol.高密度脂蛋白胆固醇水平极高者的冠状动脉钙化用于风险分层
JACC Adv. 2024 Aug 29;3(10):101217. doi: 10.1016/j.jacadv.2024.101217. eCollection 2024 Oct.

本文引用的文献

1
Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?高密度脂蛋白胆固醇升高能预防心血管疾病吗?
J Clin Endocrinol Metab. 2024 Jan 18;109(2):321-332. doi: 10.1210/clinem/dgad406.
2
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.奥比西曲匹与依折麦布联合作为高强度他汀类药物治疗的辅助治疗:一项随机2期试验。
J Clin Lipidol. 2023 Jul-Aug;17(4):491-503. doi: 10.1016/j.jacl.2023.05.098. Epub 2023 Jun 3.
3
Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality.极高密度脂蛋白胆固醇水平与心血管疾病死亡率
Am J Cardiol. 2023 Feb 1;188:120-121. doi: 10.1016/j.amjcard.2022.10.050. Epub 2022 Dec 5.
4
Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease.高密度脂蛋白胆固醇水平与冠心病事件的种族相关性。
J Am Coll Cardiol. 2022 Nov 29;80(22):2104-2115. doi: 10.1016/j.jacc.2022.09.027.
5
U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women.载脂蛋白 A1 水平与男性和女性死亡率风险之间的 U 型关系。
Eur J Prev Cardiol. 2023 Mar 1;30(4):293-304. doi: 10.1093/eurjpc/zwac263.
6
High-density lipoprotein revisited: biological functions and clinical relevance.高密度脂蛋白再探:生物学功能与临床相关性。
Eur Heart J. 2023 Apr 21;44(16):1394-1407. doi: 10.1093/eurheartj/ehac605.
7
High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients.高 HDL(高密度脂蛋白)胆固醇会增加高血压患者的心血管风险。
Hypertension. 2022 Oct;79(10):2355-2363. doi: 10.1161/HYPERTENSIONAHA.122.19912. Epub 2022 Aug 15.
8
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations.高密度脂蛋白胆固醇水平与高危人群不良心血管结局的关系。
JAMA Cardiol. 2022 Jul 1;7(7):672-680. doi: 10.1001/jamacardio.2022.0912.
9
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease.习惯性饮酒与心血管疾病风险的关联。
JAMA Netw Open. 2022 Mar 1;5(3):e223849. doi: 10.1001/jamanetworkopen.2022.3849.
10
The power of genetic diversity in genome-wide association studies of lipids.遗传多样性在全基因组关联研究脂质中的作用。
Nature. 2021 Dec;600(7890):675-679. doi: 10.1038/s41586-021-04064-3. Epub 2021 Dec 9.

载脂蛋白 B 与非高密度脂蛋白胆固醇在动脉粥样硬化性心血管疾病风险评估中的应用:探索与解释“U”型曲线。

High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve.

机构信息

Division of Cardiology, Department of Medicine, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, USA.

Virginia Commonwealth University Health Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

出版信息

Curr Cardiol Rep. 2023 Dec;25(12):1725-1733. doi: 10.1007/s11886-023-01987-3. Epub 2023 Nov 16.

DOI:10.1007/s11886-023-01987-3
PMID:37971636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10898346/
Abstract

PURPOSE OF REVIEW

Review updates for the association of HDL-cholesterol with atherosclerotic cardiovascular disease (ASCVD) and discuss the approach to incorporating HDL-cholesterol within risk assessment.

RECENT FINDINGS

There is a U-shaped relationship between HDL-cholesterol and ASCVD. Both low HDL-cholesterol (< 40 mg/dL in men, < 50 mg/dL in women) and very-high HDL-cholesterol (≥ 80 mg/dL in men) are associated with a higher risk of all-cause and ASCVD mortality, independent from traditional risk factors. There has been inconsistency for the association between very-high HDL-cholesterol and mortality outcomes in women. It is uncertain whether HDL-cholesterol is a causal ASCVD risk factor, especially due to mixed results from Mendelian randomization studies and the collinearity of HDL-cholesterol with established risk factors, lifestyle behaviors, and socioeconomic status. HDL-cholesterol is a risk factor or risk enhancer in primary prevention and high-risk condition in secondary prevention when either low (men and women) or very-high (men). The contribution of HDL-cholesterol to ASCVD risk calculators should reflect its observed U-shaped association with all-cause and ASCVD mortality.

摘要

目的综述

回顾高密度脂蛋白胆固醇(HDL-C)与动脉粥样硬化性心血管疾病(ASCVD)的相关性,并讨论在风险评估中纳入 HDL-C 的方法。

最新发现

HDL-C 与 ASCVD 之间存在 U 型关系。低 HDL-C(男性<40mg/dL,女性<50mg/dL)和极高 HDL-C(男性≥80mg/dL)均与全因和 ASCVD 死亡率升高相关,独立于传统危险因素。极高 HDL-C 与女性死亡率之间的相关性存在不一致性。HDL-C 是否是 ASCVD 的因果风险因素尚不确定,特别是由于孟德尔随机化研究和 HDL-C 与已确立的风险因素、生活方式行为以及社会经济地位之间的共线性导致结果混杂。在一级预防中,HDL-C 是原发性预防的危险因素或危险因素增强剂,在二级预防中,无论男性还是女性,低(<40mg/dL)或极高(≥80mg/dL)HDL-C 均是高危条件。HDL-C 对 ASCVD 风险计算器的贡献应反映其与全因和 ASCVD 死亡率呈 U 型关系。